Development of Inducible Leucine-rich Repeat Kinase 2 (LRRK2) Cell Lines for Therapeutics Development in Parkinson’s Disease

Title
Development of Inducible Leucine-rich Repeat Kinase 2 (LRRK2) Cell Lines for Therapeutics Development in Parkinson’s Disease
Authors
Keywords
Parkinson’s disease (PD), Leucine-rich repeat kinase 2 (LRRK2), Dopaminergic cell lines, RNAi, Kinase assay, Cell viability
Journal
Neurotherapeutics
Volume 10, Issue 4, Pages 840-851
Publisher
Springer Nature
Online
2013-08-21
DOI
10.1007/s13311-013-0208-3

Ask authors/readers for more resources

Reprint

Contact the author

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started